U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 1908

1.
Extracellular vesicle-packaged miR-4253 secreted by cancer-associated fibroblasts facilitates cell proliferation in gastric cancer by inducing macrophage M2 polarization
Xinxing Duan, Xiong Yu, Jin Gan
Cancer Biol Ther. 2024; 25(1): 2424490. Published online 2024 Nov 6. doi: 10.1080/15384047.2024.2424490
PMCID:
PMC11542604
AbstractArticlePDF–16M
2.
TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway
Lizhi Lin, Jialiang Wen, Tiansheng Xu, Yuhao Si
Cancer Biol Ther. 2024; 25(1): 2424570. Published online 2024 Nov 4. doi: 10.1080/15384047.2024.2424570
PMCID:
PMC11540099
AbstractArticlePDF–5.8M
3.
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT3
Zhilin Chen, Lu Xu, Shibin Lin, Hongjun Huang, Qing Long, Jiwei Liu
Cancer Biol Ther. 2024; 25(1): 2420383. Published online 2024 Nov 2. doi: 10.1080/15384047.2024.2420383
PMCID:
PMC11540090
AbstractArticlePDF–2.3M
4.
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
Xin Wang, Guojie Feng, Xiongtao Yang, Nuo Yu, Ziyu Zheng, Jiao Li, Xiaozheng Kang, Xiankai Chen, Ruixiang Zhang, Yong Li, Zhen Wang, Lei Deng, Tao Zhang, Wenyang Liu, Jianyang Wang, Wenqing Wang, Qinfu Feng, Zefen Xiao, Zongmei Zhou, Nan Bi, Yin Li, Jianjun Qin
Cancer Biol Ther. 2024; 25(1): 2417464. Published online 2024 Oct 27. doi: 10.1080/15384047.2024.2417464
PMCID:
PMC11520572
AbstractArticlePDF–991K
5.
Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling
Jianjun Wang, Qifan Jia, Jingyao Sun, Sen Wu, Li Wei, Wenjian Yao
Cancer Biol Ther. 2024; 25(1): 2408042. Published online 2024 Sep 28. doi: 10.1080/15384047.2024.2408042
PMCID:
PMC11445925
AbstractArticlePDF–7.0M
6.
FASN contributes to ADM resistance of diffuse large B-cell lymphoma by inhibiting ferroptosis via nf-κB/STAT3/GPX4 axis
Xing Zhong, Weiwei Zhang, Weiming Zhang, Nasha Yu, Wuping Li, Xiangxiang Song
Cancer Biol Ther. 2024; 25(1): 2403197. Published online 2024 Sep 30. doi: 10.1080/15384047.2024.2403197
PMCID:
PMC11445901
AbstractArticlePDF–8.3M
7.
Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-negative early breast cancer
Ying Xu, Yingxue Qi, Zhongyu Lu, Yuan Tan, Dongsheng Chen, Haijun Luo
Cancer Biol Ther. 2024; 25(1): 2405060. Published online 2024 Sep 20. doi: 10.1080/15384047.2024.2405060
PMCID:
PMC11418226
AbstractArticlePDF–416K
8.
EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein
Rongqi Guo, Yihui Wei, Yating Du, Luyue Liu, Haoqi Zhang, Ruiying Ren, Ruili Sun, Tingting Zhang, Xiwen Xiong, Lijun Zhao, Hongfei Wang, Xiaofang Guo, Xiaofei Zhu
Cancer Biol Ther. 2024; 25(1): 2402588. Published online 2024 Sep 17. doi: 10.1080/15384047.2024.2402588
PMCID:
PMC11409494
AbstractArticlePDF–2.9M
9.
HSPB8-BAG3 chaperone complex modulates cell invasion in intrahepatic cholangiocarcinoma by regulating CASA-mediated Filamin A degradation
Bo Shu, Yu Wen, Ronghua Lin, Chao He, Cailan Luo, Fazhao Li
Cancer Biol Ther. 2024; 25(1): 2396694. Published online 2024 Aug 31. doi: 10.1080/15384047.2024.2396694
PMCID:
PMC11370900
AbstractArticlePDF–5.3M
10.
Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer
Hui Shan, Guangyu Tian, Yeqing Zhang, Zhiyuan Qiu
Cancer Biol Ther. 2024; 25(1): 2392341. Published online 2024 Aug 20. doi: 10.1080/15384047.2024.2392341
PMCID:
PMC11340766
AbstractArticlePDF–1.6M
11.
Expression and clinical significance of NLRC5 in hepatocellular carcinoma
Xiangyu Ma, Shangkun Ning, Tong Sun, Mei Liu, Jibing Liu
Cancer Biol Ther. 2024; 25(1): 2390205. Published online 2024 Aug 12. doi: 10.1080/15384047.2024.2390205
PMCID:
PMC11321415
AbstractArticlePDF–1.7M
12.
KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis
Juan Zhang, Zhihan Li, Jiaxu Han, Zhongtao Tian, Qingyu Meng, Wenbo Niu
Cancer Biol Ther. 2024; 25(1): 2385172. Published online 2024 Aug 3. doi: 10.1080/15384047.2024.2385172
PMCID:
PMC11299624
AbstractArticlePDF–15M
13.
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
Zhen Liu, Xiao-Yang Wang, Han-Wei Wang, Shan-Ling Liu, Chao Zhang, Feng Liu, Ying Guo, Feng-Hou Gao
Cancer Biol Ther. 2024; 25(1): 2385517. Published online 2024 Aug 1. doi: 10.1080/15384047.2024.2385517
PMCID:
PMC11296530
AbstractArticlePDF–2.6M
14.
Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
Yingying Yang, Junru Shen, Peiyuan Deng, Ping Chen
Cancer Biol Ther. 2024; 25(1): 2380023. Published online 2024 Jul 24. doi: 10.1080/15384047.2024.2380023
PMCID:
PMC11271126
AbstractArticlePDF–22M
15.
Natural killer cell memory: challenges and opportunities for cancer immunotherapy
Yuhua Qu, Anhui Zeng, Yulu Cheng, Shengchun Li
Cancer Biol Ther. 2024; 25(1): 2376410. Published online 2024 Jul 10. doi: 10.1080/15384047.2024.2376410
PMCID:
PMC11238922
AbstractArticlePDF–1.1M
16.
Jmjd2c maintains the ALDHbri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma
Min Wang, Yuling Hu, Feng Cai, Lili Guo, Yimin Mao, Yingmin Zhang
Cancer Biol Ther. 2024; 25(1): 2373447. Published online 2024 Jul 8. doi: 10.1080/15384047.2024.2373447
PMCID:
PMC11232651
AbstractArticlePDF–6.1M
17.
MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3
Chun Peng, Xiaoqing Li, Yuhui Yao, Yu Nie, Lingyao Fan, Chuandong Zhu
Cancer Biol Ther. 2024; 25(1): 2373497. Published online 2024 Jul 5. doi: 10.1080/15384047.2024.2373497
Correction in:
Cancer Biol Ther. 2024; 25(1): 2389605.
PMCID:
PMC11229718
AbstractArticlePDF–7.4M
18.
Correction
Cancer Biol Ther. 2024; 25(1): 2375109. Published online 2024 Jul 1. doi: 10.1080/15384047.2024.2375109
Corrects:
Cancer Biol Ther. 2018; 19(12): 1128–1138.
PMCID:
PMC11218795
CorrectionPDF–782K
19.
Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma
Nicole M. Naranjo, Anne Kennedy, Anna Testa, Cecilia E. Verrillo, Adrian D. Altieri, Rhonda Kean, D. Craig Hooper, Jindan Yu, Jonathan Zhao, Oliver Abinader, Maxwell W. Pickles, Adam Hawkins, William K. Kelly, Ramkrishna Mitra, Lucia R. Languino
Cancer Biol Ther. 2024; 25(1): 2364433. Published online 2024 Jun 26. doi: 10.1080/15384047.2024.2364433
PMCID:
PMC11212568
AbstractArticlePDF–1.6M
20.
Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model
JiaMin Huang, Eva Michaud, Surashri Shinde-Jadhav, Sabina Fehric, Gautier Marcq, Jose Joao Mansure, Fabio Cury, Fadi Brimo, Ciriaco A. Piccirillo, Wassim Kassouf
Cancer Biol Ther. 2024; 25(1): 2365452. Published online 2024 Jun 11. doi: 10.1080/15384047.2024.2365452
PMCID:
PMC11174127
AbstractArticlePDF–2.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center